Prognostic impact of CD133 expression in Endometrial Cancer Patients

To assess the impact of CD133 expression on the prognosis of endometrioid endometrial carcinoma (EEC). We retrospectively assessed CD133 expression in tissue microarray of 116 surgically treated FIGO I-III EEC. Tumors with ≥10% of CD133-expressing cells were considered CD133-positive (CD133+). On th...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Udgivet i:	Sci Rep
Main Authors:	Mancebo, G., Sole-Sedeno, J. M., Pino, O., Miralpeix, E., Mojal, S., Garrigos, L., Lloveras, B., Navarro, P., Gibert, J., Lorenzo, M., Aran, I., Carreras, R., Alameda, F.
Format:	Artigo
Sprog:	Inglês
Udgivet:	Nature Publishing Group UK 2017
Fag:	Article
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC5550511/ https://ncbi.nlm.nih.gov/pubmed/28794448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-08048-0
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Prognostic impact of CD133 expression in Endometrial Cancer Patients

Lignende værker